Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 13,149 | 9,493 | 155 | 206 | 239 |
| Cost of Goods | 1,013 | N/A | N/A | N/A | N/A |
| Gross Profit | 12,136 | 9,493 | 155 | 206 | 239 |
| Operating Expenses | 51,550 | 51,179 | 65,077 | 57,661 | 49,393 |
| Operating Income | -39,401 | -41,686 | -64,922 | -57,455 | -49,154 |
| Interest Expense | 3,093 | 3,089 | 2,998 | 0 | 0 |
| Other Income | 1,147 | 1,368 | 1,769 | -738 | 1,085 |
| Pre-tax Income | -41,347 | -43,407 | -66,151 | -58,193 | -48,069 |
| Income Tax | 20 | 8 | 10 | 17 | 14 |
| Net Income Continuous | -41,367 | -43,415 | -66,161 | -58,210 | -48,083 |
| Net Income | $-41,367 | $-43,415 | $-66,161 | $-58,210 | $-48,083 |
| EPS Basic Total Ops | -10.05 | -10.64 | -16.34 | -14.54 | -11.84 |
| EPS Basic Continuous Ops | -9.99 | -10.68 | -16.30 | -14.59 | -11.90 |
| EPS Diluted Total Ops | -10.05 | -10.64 | -16.34 | -14.54 | -11.84 |
| EPS Diluted Continuous Ops | -9.99 | -10.68 | -16.30 | -14.59 | -11.90 |
| EBITDA(a) | $-37,627 | $-40,101 | $-63,495 | $-56,092 | $-48,956 |